Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH4 | Q9H3N8 | 7/20 | 0.46 |
| ▸ | BRAF | P15056 | 3/20 | 0.44 |
| ▸ | MAPK14 | Q16539 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.42 |
| ▸ | RAF1 | P04049 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28265699 | 0.94 | MAPK14 (0.46) | HRH4BRAFMAPK14KMT2AALDH1A1 | |
| SCHEMBL15757388 | 0.84 | NUDT1 (0.52) | HRH4BRAFMAPK14KMT2AALDH1A1 | |
| SCHEMBL28267602 | 0.83 | HRH4 (0.47) | HRH4BRAFALDH1A1TLR8SMN1; SMN2 | |
| SCHEMBL28265742 | 0.83 | TLR8 (0.46) | HRH4MAPK14KMT2AALDH1A1TLR8 | |
| SCHEMBL17315273 | 0.83 | NUDT1 (0.42) | HRH4BRAFMAPK14KMT2AALDH1A1 | |
| SCHEMBL28267598 | 0.82 | TLR8 (0.55) | HRH4MAPK14KMT2AALDH1A1TLR8 | |
| SCHEMBL28152287 | 0.81 | ALDH1A1 (0.46) | HRH4BRAFMAPK14ALDH1A1RAF1 | |
| SCHEMBL28152280 | 0.81 | HRH4 (0.49) | HRH4TLR8TP53MAPT | |
| SCHEMBL28265859 | 0.80 | TLR8 (0.43) | HRH4KMT2AALDH1A1TLR8MAPT | |
| SCHEMBL15757125 | 0.79 | NUDT1 (0.50) | BRAFMAPK14KMT2AALDH1A1TLR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105143206-B | Pyrimidine -2,4- diamine derivative for treating cancer | 托马斯·黑勒戴药物研究基金会 | 2019-01-15 | — | — | CN | claimed |
| CN-105143206-B | Pyrimidine -2,4- diamine derivative for treating cancer | 托马斯·黑勒戴药物研究基金会 | 2019-01-15 | — | — | CN | disclosed |
| CN-106794181-A | MTH1 inhibitors for the treatment of inflammatory and autoimmune conditions | 托马斯·黑勒戴药物研究基金会 | 2017-05-31 | — | — | CN | disclosed |